Montilla (Ona consultant) on the “Minamata” oncological syndrome of the former Pertusola of Crotone

Doctor Pasquale Montilla

by PASQUALE MONTILLA*

The Calabria Region has declared that it does not have an efficient and credible tool to monitor the tumor incidence data recorded in the territory of Crotone in the former Pertusola area. The epidemiological data on the incidence of tumors in Crotone, an area with a high environmental and health impact, cannot be accredited to the World Health Organization’s data call for the preparation of the periodic Cancer incidence in Five Continents report because they are incomplete. This chronic incompetent interpretation of non-linear epidemiological data has currently forced a forced remodulation of a realignment project of the Tumor registry of the Calabria Region and a revision of the information system with a radical approach.
READ ALSO HERE. Sin Crotone, the extraordinary commissioner requests the ‘necessary and urgent’ intervention of the carabinieri

Ezio Bonanno, president of Ona

In short, a failure was documented. It is therefore confirmed that oncological prevention in areas with high environmental pressure and a high index of deprivation in Calabria has therefore been carried out for decades at reduced hours. Failure to carry out linear and precise epidemiological investigations and the launch of primary oncological prevention and not having considered oncological prevention as a strong point is a violation of the anthropological statute which ultimately created a cultural by-product of medical science and a leap in quality of oncological damage right away. We need to focus on onco-toxicological screening on genomic targets to identify patients contaminated by toxic chemical agents with carcinogenic action and turn back the biological damage clock with targeted treatments.

Hanter, a Harvard epidemiologist, stated in Molecular Epidemiology of Cancer in 2005 that the integration of traditional epidemiology, molecular biology and priphyllation genetics will produce a resurgent form of epidemiology that is much more powerful in its ability to prevent cancer. This means that molecular epidemiology represents, together with other toxicological screening, the future of primary cancer prevention. The key to acceleration is to position the exposome as a future scientific reference point for precision medicine in chronic poisonings from industrially produced heavy metals and radioactive radioisotopes.

Molecular epidemiology of exposomes that identifies risks to human health based on biomarkers of environmental exposures has unfortunately never been indicatedaware that high-impact environmental exposures can influence genetically driven oncological processes.

*Scientific Consultant Medical Oncologist ONA Rome